bio

Gauri V. Pawar, M.D., F.A.A.N.

Office Address: West Virginia University Department of Neurology 1 Medical Center Drive, PO Box 9180 Morgantown, WV 26506-9180 Phone: (304) 293-3527 Fax: (304) 293-3352 Email: gpawar@hsc.wvu.edu

Current Position:
Professor, Dept. of Neurology Education:

Degree - M.B.B.S. Bachelor of Medicine and Bachelor of Surgery School - Government Medical College, Miraj, India. Jun 1985 - Dec 1990

Residency Internal Medicine Government Medical College, Miraj, India. Jan 1991- May 1992 ECFMG certificate Nov 1993

Postgraduate/Postdoctoral training:

Neurology Residency University of Medicine and Dentistry of New Jersey, Newark, NJ Jul 1994 - Jun 1998

Clinical Neurophysiology Fellowship West Virginia University, Morgantown, WV Jul 1998 - Jun 1999

Board Certification:

American Board of Psychiatry and Neurology (ABPN) – Neurology May 1999 - Present ABPN - Clinical Neurophysiology Mar 2003 - Dec 2013 Recertified May 2018 - Present

Licensure:
Revised 6/21/2018
West Virginia 19797 May 1999 - Present Current Academic Positions and Appointments:

Vice-Chair for Education, Dept. of Neurology Jul 2017 – Present Residency Program Director, Dept. of Neurology Mar 2007 - Present Vice-Chair for Business Affairs and Compliance, Dept. of Neurology Jan 2004 - Present

Previous Administrative Appointments:
Administrative Chief Resident University of Medicine and Dentistry of New Jersey, Newark, NJ Jul 1997 -Jun 1998 Previous Academic Appointments:

Associate Graduate Faculty, WVU Ofc of Research and Graduate Education Jun 2017 – Present Associate Professor of Neurology, WVU SOM Jul 2007 – Jun 2018 Graduate Faculty, WVU Ofc of Research and Graduate Education Feb 2008 – Mar 2015 Assistant Professor of Neurology, WVU SOM Jul 1999 - Jun 2007

Other Appointments: Adjunct Clinical Faculty, WV School of Osteopathic Medicine Jul 2004 - Jun 2006

Hospital Appointments:
Member, Subject Matter Expert (SME)-EPIC Implementation WVU Hospitals Jul 2006 - Jun 2009 Member, “No Show” Reduction-EPIC Implementation WVU Hospitals Jul 2006 - Jun 2009 Chair, Ambulatory Care Management Committee (ACMC) WVU Hospitals Jul 2007- Jun 2008 Vice Chair, ACMC, WVU Hospitals Jul 2006 - Jun 2007 Member, Physician Office Center Safety Committee WVU Hospitals Jul 2006 - Jun 2007 Member, ACMC, WVU Hospitals Jun 2004 - Jul 2006 Member, Serving Together Achieving Results team (STAR) WVU Hospitals Dec 2002 - Nov 2009

Awards and Honors:
Fellow, American Academy of Neurology Apr 2015 Resident Teaching Award, Dept. of Neurology, WVU. Jul 2011 - Jun 2012 Resident Teaching Award, Dept. of Neurology, WVU. Jul 2009 - Jun 2010 Resident Teaching Award, Dept. of Neurology, WVU. Jul 2008 - Jun 2009 Resident Teaching Award, Dept. of Neurology, WVU. Jul 2007 - Jun 2008 Resident Teaching Award, Dept. of Neurology, WVU. Jul 2001 - Jun 2002
Revised 6/21/2018
Neurology Resident of the Year, Dept. of Neurology, UMDNJ. Jun 1998 Professional Societies:

Fellow, American Academy of Neurology (F.A.A.N.) Apr 2015 - present Member, American Academy of Neurology Jan 1998 - present Member, West Virginia State Medical Association May 1999 - present Member, Monongalia County Medical Association Jul 1999 - present

National Committees:
Member, ACGME Pain Medicine Program Requirement May 2018 – present Revision Subcommittee Member, ACGME Neurology Program Requirement Jan 2018 – present Revision Subcommittee Member, ABPN Neurology Pilot MOC Examination Committee Jan 2018 - present Member, ACGME Neurology Review Committee (NRC) Jul 2017 – Jun 2023 Member, AAN CNPD (Consortium of Neurology Program Directors) Revamp Workgroup Apr 2017- Jun 2018 Member, AAN Resident Leadership Subcommittee Apr 2017 - Apr 2019 Mentor, AAN Enhanced Resident Leadership Program Apr 2013 - Apr 2017 Member, Association of University Professors of Neurology (AUPN) Program Director Liaisons Group Apr 2016 - Apr 2019 Member, AAN Enhanced Resident Leadership Program Apr 2013 - Apr 2017 Chair, AAN Residency In-Service Training Examination (RITE) Advisory Panel Apr 2011 - Apr 2017 Member, AAN Graduate Education Subcommittee (GES) Apr 2011 - Apr 2017 Member, AAN Examination Subcommittee Apr 2011 - Apr 2017 Member, AAN GES Clinical Skills Evaluation Work Group Apr 2009 - Apr 2011 Member, AAN GES Basic Science Curriculum Work Group Apr 2009 - Apr 2011 Section Chief Physiology, AAN RITE Advisory Panel Apr 2009 - Apr 2011 Member, AAN RITE Advisory Panel Apr 2005 - Apr 2009 Examiner, American Board of Psychiatry and Neurology (ABPN) May 2003 - Oct 2010

State Committees:
Member, WV State Stroke Task Force Jul 2004 - Jun 2008

Institutional Committees: WVU School of Medicine: Lead, Sports Medicine Special Program Review, GMEC Jul 2018 Member, Chair of Ophthalmology Search Committee Jan 2018 Lead, Cytopathology Special Program Review, GMEC Oct 2017 Member, GME Task Force Aug 2017 - present Member, Level 3 Grievance committee, GMEC Apr 2017 Member, Clinical Learning Environment Review site visit, GMEC Feb 2016 Member, Level 3 Grievance committee, GMEC Sep 2015 Member, Neurosurgery Special Program Review, GMEC Oct 2014
Revised 6/21/2018
Member, Clinical Learning Environment Review site visit, GMEC May 2014 Member, Patient Safety Subcommittee, GMEC Jul 2013 - Present Member, Internal Review Committee for Hematology/Oncology Fellowship, GMEC Oct 2012 Member, Internal Review Committee for Dept. of Forensic Psychiatry, GMEC Apr 2011 Chair, Generic Post Grad Survey & Employer Survey Committee, GMEC Feb 2010 Member, GME Review Workgroup, Commissioned by the ELG Oct 2010 Member, Program Director Job Description work group, GMEC Apr 2010 - Jan 2011 Member, Transitional Year Program Evaluation Committee May 2007- Present Member, Internal Review Committee for Dept. of Nephrology, GMEC Sep 2009 Member, Internal Review Committee for Dept. of Cardiology, GMEC Sep 2009 Member, Internal Review Committee for Dept. of Urology, GMEC May 2007 Member, Internal Review Committee for Dept. of CT Surgery, GMEC Mar 2007 Member, Graduate Medical Education Committee (GMEC) Mar 2007- Present

WVU School of Pharmacy: Member, PhD dissertation committee for Abhijeet Bhanegaonkar Feb 2008 - Apr 2012 Member, PhD dissertation committee for Vivek Pawar Feb 2005 - Apr 2008

Department of Neurology: Vice Chair for Education Jul 2017 - present Chair, Neurology Program Evaluation Committee (PEC) May 2013 - Present Member, Clinical Competency Committee (CCC) May 2013 - Present Member, Clinical Neurophysiology Fellow Education Committee Mar 2007 - Jun 2014 Chair, Neurology House staff Education Committee Mar 2007- Apr 2013 Director, Neurology Residency Mar 2007- present Liaison for Social Justice Apr 2000 - Present Member, Neurology Education Committee Jan 2003 - Feb 2007 Member, Promotion and Tenure Committee Jul 2002 - Jun 2004

Ad hoc Reviewer:
AAN, Assessment Question Reviewer for Digital Education Resources NeuroLearn – REM Sleep Behavior Disorder Jan 2016 Health and Quality of Life Outcomes, Reviewer, “Impact of Multiple Sclerosis And its treatment on patients - A systematic review of the Evidence” Jun 2012 Neurorehabilitation and Neural Repair Reviewer, “Critical Illness Neuropathy” Sep 2000 Continuum – Trauma: Reviewer, “Adult Traumatic Brain Injury” 1999 - 2000

Revised 6/21/2018
Reviews and Study Sections:

Member, NIH – Data Safety Monitoring Board (DSMB) for ALS Clinical trial Sept 2005 - Jun 2008


Grants and Contracts:
1. Sponsor: Medical University of South Carolina Status: In Progress (2014 - ongoing) PI: Ansaar Rai, MD Sub I: Jeffrey Carpenter, MD Sohyun Boo, MD Gauri Pawar, MD Jennifer Domico, RN IRB No.: 24604/1412529586 Protocol: None Title: POSITIVE: Perfusion Imaging Selection of Ischemic Stroke Patients for Endovascular Therapy

2. Carrots and sticks- Trainee self-motivation and to reduced door-to-needle time in acute ischemic stroke Status: In Progress (2016 - ongoing) PI: Gauri Pawar, MD Sub I: Aman Dabir, MD IRB No.: 1603035184 Matthew Smith, MD

3. Sponsor: Cytokinetics, Inc. Status: In Progress (2016 - ongoing) PI: Shumaila Sultan MD. Sub I: Gauri Pawar, MD IRB No. 1609296113 Protocol: CY 4033 Phase 3, Open-Label Extension Study of Tirasemtiv for Patients with Amyotrophic Lateral Sclerosis (ALS) Who Completed VITALITY-ALS (CY4031)

Previously Funded Grants and Contracts:
1. Sponsor: NIH, ALSA, Cephalon, Inc. Status: Completed (2002-2005) PI: Laurie Gutmann MD Sub I: Ludwig Gutmann, MD Gauri Pawar, MD IRB No.: 15157 Title: “Clinical Trial of IGF-1 in Patients with Amyotrophic Lateral Sclerosis (ALS)”

2. Sponsor: MYLAN Pharmaceuticals, Inc. Status: Completed (2002-2005) PI: Ludwig Gutmann, MD Sub I: John Brick, MD Gauri Pawar, MD IRB No.: 14579 Protocol: APO401 Title: “An Open-Label Study to Evaluate the Long-Term Safety and Effectiveness of Sub-Cutaneous Injections of Apomorphine in the Treatment of “Off” Episodes in patients with “On-Off” or “WearingOff” Effects Associated with Late-Stage Parkinson’s Disease

3. Sponsor: MYLAN Pharmaceuticals, Inc. Status: Completed (2000-2002) PI: Ludwig Gutmann, MD Sub I: John Brick, MD Gauri Pawar, MD IRB No.: 15115 Protocol: APO302
Revised 6/21/2018
Title: “A Prospective, Randomized, Placebo-Controlled, Parallel Groups Study of the Continued Efficacy and Safety of Subcutaneous Injections of Apomorphine in the Treatment of “Off” Episodes in Patients with “On-Off” or “Wearing Off” Effects Associated with Late-Stage Parkinson’s Disease after Apomorphine Use for at Least a Three Month Duration”

4. Sponsor: MYLAN Pharmaceuticals, Inc. Status: Completed (2002) PI: Ludwig Gutmann, MD Sub I: John Brick, MD Gauri Pawar, MD IRB No.: 15069 Protocol: APOM0073 Title: “A Phase II Open-Label Pharmacokinetic (PK) and Pharmacodynamic (PD) Study Following Subcutaneous Administration of Apomorphine HC1 to Patients with Idiopathic Parkinson’s Disease”

5. Sponsor: Boehringer Ingelheim Status: Completed (2004-2008) PI: Claudette Brooks MD Sub I: Gauri Pawar, MD, David Libell, MD John Brick, MD IRB No.: 16239 Protocol: 9.159 Title: “PRoFESS: Prevention Regimen for effectively avoiding Second Strokes: A double-blind, active and placebo controlled study of Aggrenox® vs. clopidogrel, with and without Micardis®”

6. Sponsor: Boehringer Ingelheim Status: Completed (2005-2011) PI: Ludwig Gutmann, MD Sub I: Gauri Pawar, MD
John F. Brick, MD Cathrin Buetefisch, MD Monique J.L. Leys, MD IRB No.: 16501 Protocol: 248.538 Title: A Two Year Open Label, Randomized, Parallel Group, Blinded Assessment Ophthalmologic Safety Study of Pramipexole IR versus Ropinirole in Early Parkinson’s Disease Patients

7. Sponsor: NINDS Status: Completed (2006-2007) PI: Laurie Gutmann, MD Sub I: Gauri Pawar, MD Ludwig Gutmann, MD Christopher Nance, MD IRB No.: 16807 Protocol: N/A Title: Amyotrophic Lateral Sclerosis Research Group [ALS RG] Collection of Data and Biomaterial for Repository Banking to Facilitate Research into the Etiology of Amyotrophic Lateral Sclerosis and Related Motor Neuron Diseases.

8. Sponsor: NINDS Status: Completed (2007-2008) PI: Laurie Gutmann, MD Sub I: Gauri Pawar, MD Ludwig Gutmann, MD Geoffrey Graeber, MD Christopher Nance, MD IRB No.: 16942 Protocol: None Title: A Multi-Center, Single-Blind, Randomized Study Comparing Thymectomy to No Thymectomy in Non-Thymomatous Myasthenia Gravis (MG) Patients Receiving Prednisone.

9. Sponsor: MYLAN Pharmaceuticals, Inc. Status: Completed (2003-2004)
Revised 6/21/2018
PI: Ludwig Gutmann MD Sub I: John Brick, MD Gauri Pawar, MD IRB No.: 15896 Protocol: APO304 Title: “A Survey of Patient Preference for Apomorphine Subcutaneous Injections Using the Injector Pen or Ampule/Syringe in the treatment of “Off” Episodes with Subcutaneous Injections of Apomorphine for at Least Three Months. 10. Sponsor: NOVARTIS Status: Completed (2007-2012) PI: Gauri Pawar, MD Sub I: Christopher Nance, MD, Claudette E. Brooks, MD, Laurie Gutmann, MD, Ansaar T. Rai, MD and Anthony D. Realini, MD IRB No.: 17232 Protocol: CFTY720D2309 Title: A 24-Month Double-Blind, Randomized, Multicenter, Placebo-Controlled, Parallel-Group Study Comparing the Efficacy and Safety of 0.5 mg and 1.25 mg Fingolimod (FTY720 Administered Orally Once Daily Versus Placebo in Patients with Relapsing-Remitting Multiple Sclerosis.

11. Sponsor: NOVARTIS Status: Completed (2007-2011) PI: Gauri Pawar, MD Sub I: Christopher Nance, MD Claudette Brooks, MD Laurie Gutmann, MD Ansaar T. Rai, MD Anthony Realini, MD IRB No.: 17272 Protocol: CFTY20D2302 Title: A 12-month Double-Blind, Randomized, Multicenter, Active-Controlled, Parallel-Group Study Comparing the Efficacy and Safety of 0.5 Mg and 1.25 Mg Fingolimod (FTY720) Administered Orally Once Daily Versus Interferon β-1a (Avonex7) Administered I.M. Once Weekly in Patients with Relapsing- remitting Multiple Sclerosis with Optional Extension Phase

12. Sponsor: ALLERGAN PI: Laurie Gutmann, MD Status: Completed (2009-2012) PI: Gauri Pawar, MD IRB No.: 21758 Protocol: MedAff BTX-0718 Title: CD PROBE – Cervical Dystonia, Patient Registry for Observation of BOTOX Efficacy

13. Abnormal MRI, MS or Fear of MS? Status: Completed (2012-2015) PI: Gauri Pawar, MD Sub I: Aram Zabeti, MD IRB No.: 23930

14. Sponsor: BIOGEN IDEC Status: Completed (2008-2015) PI: John F. Brick, MD Sub I: Gauri Pawar, MD Ludwig Gutmann MD IRB No.: 20805 Protocol: 101MS401 Title: Tysabri Global Observational Program in Safety.

15. Hemorrhagic Stroke Prognostics. Status: Completed (2013-2016)
Revised 6/21/2018
PI: Gauri Pawar MD. Sub I: Ann Murray IRB No. 131002315 (KC) 16. Sponsor: Receptos, Inc. Status: Closed (2015) PI: Javier Gonzalez, MD Sub I: Gauri Pawar, MD John F. Brick, MD Kristina Lopez, MD Ann Murray , MD IRB No.: 1410459090 Protocol: RPC01-301 Title: A Phase 3, Multi-Center, Randomized, Double-Blind, Double-Dummy, Active-Controlled, Parallel Group Study to Evaluate the Efficacy and Safety of RPC1063 Administered Orally to Relapsing Multiple Sclerosis Patients

17. Sponsor: Cytokinetics Status: Completed (2013-2014) PI: Laurie Gutmann, MD Sub I: Ludwig Gutmann, MD PI: Christopher Nance, MD Gauri Pawar, MD IRB No.: 24486/1311127299 Protocol: CYTO4026 Title: A Phase IIB, Multi-National, Double-Blind, Randomized, Placebo-Controlled Study To Evaluate The Safety, Tolerability And Efficacy of CK-2017357 In Patients With Amyotrophic Lateral Sclerosis (ALS)

18. Sponsor: Sanofi US Status: Completed (2013-2016) PI: Javier Gonzalez, MD Sub I: John F. Brick, MD Gauri Pawar, MD Kristina Lopez, MD Kimberly Wagner, MD IRB No.: 1308080924 Protocol: LPS13567 Title: A Prospective, Single-Arm, Clinical-Setting Study to Describe Efficacy, Tolerability and Convenience of Teriflunomide Treatment Using Patient Reported Outcomes (PROs) in Relapsing Multiple Sclerosis (RMS) Patients

19. CNS Toxoplasmosis Status: Completed (2014-2017) PI: Gauri Pawar, MD Sub I: Heeral Mehta, MD IRB No.: 1311129771

20. Sponsor: Cytokinetics Status: Completed (2015 - 2018) PI: Shumaila Sultan, MD Sub I: Muhammad Alvi, MD PI: Christopher Nance, MD (formerly) Gauri Pawar, MD IRB No.: 1606162563 Protocol: CYTO4031 Title: A Phase 3, Multi-National, Double-Blind, Randomized, Placebo-Controlled, Stratified, Parallel Group, Study to Evaluate the Safety, Tolerability And Efficacy of Tirasemtiv in Patients With Amyotrophic Lateral Sclerosis (ALS)

21. Unusual Amnestic Syndrome Associated with Combined Fentanyl and Cocaine Overdose (6/23/17) PI: Liv Miller Sub I: Marc Haut IRB No: 1206633777 Gauri Pawar, Uzoma Bruno Duru, MD

Clinical Responsibilities:

1. Supervising faculty on neurology inpatient service about 6-8 weeks per year. This involves caring for patients on the general neurology team and providing consultative services for patients with neurological problems on other inpatient services. Based on the severity of patients, patients are housed on floors and step-down units. It involves teaching of medical students, neurology residents at different levels in training and residents from other services including neurosurgery, internal medicine, anesthesia, psychiatry and transitional year. 2. Faculty performing nerve conduction studies and electromyography (NCS/EMG), analyzing electroencephalograms (EEG) one day per week, throughout the academic year. It involves teaching neurology residents who are rotating on clinical neurophysiology elective and technicians working in the laboratory. 3. Caring for outpatient general neurology patients one day per week, throughout the year. I perform botulinum toxin injection procedures in patient with spasticity related to head trauma, stroke, multiple sclerosis, cerebral palsy along with patients suffering from movement disorders including spasmodic torticollis, hemifacial spasm, blepharospam, or focal segmental dystonia. 4. Precepting faculty for 7-8 residents in their continuity clinic, half day per week. 5. Provided monthly outreach clinical service in Oakland, Maryland from July 1999 through December 2014 caring for patients with neurological diseases and performing 5-7 NCS/EMG studies. Undergraduate Medical Education:

1. Participate in teaching MS III and MS IV during their neurology clerkship on inpatient and outpatient service, during journal club presentation, weekly Wednesday didactics and Friday noon conferences along with grand rounds. 2. Involved in Physical Diagnosis and Clinical Integration (PDCI) program for MS I and MS II 1.0 hour spring 2011 5.75 hours Fall 2010 5.5 hours Spring 2010 4.5 hours Fall 2009 5.25 hours Fall 2008 Graduate Medical Education:

At the national level, I am involved in mentoring 2-3 neurology residents annually through the Enhanced Resident Leadership program offered by the AAN since April 2013.

As the residency Program Director in the department since March 2007, I have been involved in developing multiple changes within the program to improve the educational experience of the trainees. There are 5 residents per year, for a total of 20 residents within the department. The department was approved by ACGME to increase complement to 6 residents per year starting July 2018.

The following program improvements help the neurology residents in addition to benefitting medical students (MSIII and MSIV) as well as residents rotating from other departments like internal medicine, neurosurgery, anesthesia, psychiatry and transitional year.

1. Developed and co-ordinate a subspeciality clinic rotation, for 2 months during each academic year, so that the residents are exposed to various subspecialities (headache, neuromuscular –MDA/ALS,
Revised 6/21/2018
neuroimmunology, stroke, epilepsy, movement disorders, sleep disorders) within neurology. This was started 5 years ago. Every month, there are 2-3 residents who are scheduled on this rotation and I have teaching responsibility for ½ day every week over the past 4 years.

2. Developed various electives over the past 5 years with the help of subspeciality faculty, to include headache, neuromuscular, neuroimmunology, neuro-ophtalmology and pain.

3. Developed “Introduction to Neurology” lecture series during July and August of each academic year assists the incoming PGY2 residents with caring for patients with common neurological conditions and analysing EEGs. I teach “Neurological Examination” for 2 hours during this lecture series.

4. Developed a Epilepsy Monitering Unit rotation for 1 month each academic year that exposes residents to pediatric and adult epilepsy. 8 EMU beds and intensive care unit patients monitored by EEG are staffed by our board certified epileptologists. The residents are trained to analyse and dictate a total of at least 375 EEGs before graduation.

5. Developed and teach all of the quarterly lecture series for “Board review” for the past 5 years. This includes MCQs in various topics like neuroanatomy, neurophysiology, neuropathology, neuropharmacology and neuroimaging besides adult and pediatric clinical neurology. I modify the curriculum based on the resident educational needs and program scores on the RITE.

6. Developed a quarterly lecture series in Multiple Sclerosis and Evidence Based Medicine with the help of other departmental faculty from July 2013 through June 2016.

7. Developed Research elective where a residents works on a topic of their choice with a mentor, for 1-3 months during their training. Residents present their work at our departmental “Annual Research Day”. Residents are also encouraged to have a publication or a poster presentation at a regional or national meetings related to their work.

8. Developed 2 inpatient teams (currently general neurology and Stroke) with night float system. This was introduced 3 years ago to address seamless patient transition of care and address resident fatigue in a healthy working environment. These modifications helped to maintain resident well being.

9. Modified the resident continuity clinic, so the residents get exposure and are supervised by various subspecialty faculty. The patient seen on the inpatient service are followed by the same resident in the continuity clinic, so the residents get exposure to an acute pathology and its long term sequelae. I am a preceptor in the resident continuity clinic ½ day per week and teach 6-9 residents at different levels in training.

10. Prepare annual didactic lecture schedule ensuring a robust educational opportunity for all residents. I teach 8-10 hours of lectures during the annual didactic lectures to medical students, residents, nurses and physician assistants within the department on various topics to include neurological examination, neuromuscular disease, neuroanatomy, neurophysiology, neuroimaging and neuropharmacology.
Revised 6/21/2018
11. Prepare annual journal club schedule for the department which includes presentation by all residents and faculty to keep everyone updated with latest medical literature.

12. As a faculty on neurology inpatient service for 6-8 weeks each academic year, I am closely involved in bedside teaching of medical students and residents from multiple departments including neurology, neurosurgery, transitional year, anesthesia, psychiatry, internal medicine. Also involved in teaching nurses in the hospital and technicians from neurophysiology laboratory. Monitors and evaluates the process of transition of patient care between residents during shift change, rotation change, and transfer between services.

13. Teaching EMG/NCS one day per week to the residents on an elective rotation in clinical neurophysiology. I also have teaching responsibility for 3-4 technicians who work with me in the laboratory.

14. Teach a 2-hour lecture on “Business in Neurology” to all residents. I update residents about average new patient and return patient visits for all neurologists nationally. I discuss RVU targets, no-show rates in outpatient clinics and how it affects “patient access” and “revenue generation” etc.

15. Arrange “Billing and coding” lecture annually for all residents. Billing information is given by a personnel from the billing department. During that time, I teach coding by using examples from inpatient and outpatient medical documentation which is de-identified to maintain patient privacy.

16. Teach 1 hour lecture on “Medical Documentation” annually. I perform chart review with appropriate deidentification during part of this lecture to reinforce the importance of medical documentation.

17. Arrange an annual 1 hour lecture on “Medico-legal issues in Medicine” by Office of Risk Management.

18. Teach 1 hour lecture on “Transition of Care” annually to all residents to ensure appropriate patient care with change in shift and change in rotation.

19. ELVIS and ELVIRA Training for Neurology residents - Chemo denervation with botulinum toxin A - 2 hour lectures done in Mar. 2007, Mar 2009, Apr 2011 and Apr 2017.

20. Developed and teach “PGY2 boot camp” lectures for one hour on Fridays which started in July 2017. I have done 8 hours of lectures to PGY2 neurology residents covering Neuroanatomy through Clinical Cases book chapters by Blumenfeld. 21. I have done 1 hour of lectures to Transitional year residents on “neurological examination” annually.

Graduate Student Education:

1. In 2017, mentored and provided physician perspective to a graduate student, Ankur Dashputre, at Duquesne University School of Pharmacy on cost effectiveness in Multiple Sclerosis drugs which resulted in a publication in Journal of Managed Care & Specialty Pharmacy.

Revised 6/21/2018
2. In March 2017, participated by providing physician perspective for focus on cost effectiveness of medications during “Advanced decision modelling” course for PhD students at Pharmaceutical Systems and Policy department in WVU School of Pharmacy.

3. In Oct of 2012, 2014 and 2016, participated in teaching “Patient Reported Outcomes (PRO) Course” of Master’s degree students at Duquesne University School of Pharmacy.

4. In 2013, mentored and collaborated with 3 graduate students from Duquesne University School of Pharmacy on a systematic review of quality of life and caregiver burden in Parkinson’s disease. This resulted in a poster presentation at The Annual meeting of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) in New Orleans, LA, May 2013. The abstract was published in Value in Health 2013; 16:A107.

5. In 2011, mentored and collaborated with PhD student from WVU School of Pharmacy on qualitative study understanding health related quality of life changes and issues related to disease modifying drugs among multiple sclerosis patients. This resulted in a poster presentation at the Annual meeting of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) in Baltimore, MD. The abstract was published in Value in Health May 2011; Vol 14, Issue 3, A211

Health Professions Education:

Pharmacy Students

1. In 2015, mentored and collaborated with one Pharm D student from Duquesne University School of Pharmacy on the Impact of young-Onset Parkinson’s disease on Quality of Life. We performed a literature review which led to a poster presentation at the Annual meeting of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) at Philadelphia, PA. The abstract was published in Value in Health 2015; 18:A288.

2. In 2013, mentored and collaborated with two Pharm D students, from Duquesne University School of Pharmacy on Caregiver burden in multiple sclerosis. This led to a poster presentation at the Annual meeting of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) at New Orleans, LA. The abstract was published in Value in Health 2013; 16:A107-108.

Technicians

Teach nerve conduction testing to 3-4 technicians in clinical neurophysiology laboratory one day per week.

Community Physicians

In Feb 2003, participated in Visiting Clinician Program where community internist shadow specialist in outpatient setting.

Postgraduate Education:

1. July 1999 through June 2014 was involved in teaching clinical neurophysiology fellow with multiple lectures throughout the year and one day per week in the neurophysiology laboratory performing NCS/EMG and EEG.

Invited lectures and Presentations: National

1. Optimizing Neurology Residency Program Implementation: An Interactive Session Between Program Directors and Department Chairs, AUPN Chairs Spring Session, Apr 2018 2. Facilitator, The Clerkship and Program Directors Conference: Demonstrating Your Impact as a Medical Educator, AAN Annual Meeting Apr 2018 3. Breakout session speaker - Complement increase and switching to categorical program, Consortium of Neurology Program Director (CNPD) Business meeting, AAN Annual Meeting Apr 2018 4. Mentor, New Program Director Group Mentoring, AAN Annual Meeting Apr 2018 5. Speaker, New Program Directors Boot Camp, Topic – ACGME, CNPD Business meeting, AAN Annual Meeting Apr 2018 6. Residency In-Training Examination (RITE) Update – AAN Annual Meeting, CNPD meeting, Apr 2017 7. RITE Update – AAN Annual Meeting, CNPD meeting, Mar 2016 8. RITE Update – AAN Annual Meeting, CNPD meeting, Mar 2015 9. RITE Update – AAN Annual Meeting, CNPD meeting, Apr 2014 10. RITE Update – AAN Annual Meeting, CNPD meeting, Apr 2013 11. RITE Update – AAN Annual Meeting, CNPD meeting, Apr 2012 12. American Academy of Neurology – Toxins and Peripheral Nerves, May 2000

Invited lectures and Presentations: Local and Institutional

1. MidAtlantic Neurodiagnostic Society Annual Meeting - NCS/EMG - Oct 15, 2016 2. Transitional Year Residency – Neurological Examination – Annually in August 3. WV Family Medicine Foundation - Multiple Sclerosis - Nov 9, 2007 4. SIGN, WVU School of Medicine - Multiple Sclerosis - Mar 29, 2007 5. Student Health at WVU - Multiple Sclerosis - Mar 20, 2007 6. UHC, Clarksburg, Dept of Medicine - Multiple Sclerosis, Nov 2006 7. National Multiple Sclerosis Society, WV Chapter, Taking control of your MS, A wellness approach, May 2005 8. National Multiple Sclerosis Society, WV Chapter, An update on diagnosis and treatments of MS, Mar 2005 9. WVU, PT/OT Grand Rounds - Chemodenervation in Spasticity Management; Optimizing Therapeutic Outcomes, Jun 2004 10. National Multiple Sclerosis Society, WV Chapter, Update on Multiple Sclerosis, Mar 2004 11. West Virginia Stroke Support Group - Spasticity in Stroke, Jun 2003 12. Mid-Atlantic Regional Dystonia Symposium - Treatment Options in Dystonia, May 2003 13. WVU Department of Family Medicine Grand Rounds - Multiple Sclerosis, Jan 2003 14. WVU Department of Pharmacology Grand Rounds - Multiple Sclerosis, Jan 2003 15. WVU Neurosciences Conference - Multiple Sclerosis: Treatment in the New Millennium, Sep 22, 2001

Poster Presentation: National

Apr 2018 Quynh Vo, Pawar Gauri, Uzoma Duru. "Unusual Amnestic Syndrome Associated with Combined Fentanyl and Cocaine Overdose". Annual meeting of the American Academy of Neurology (AAN), Los Angeles, CA Jan 2018 Aman Dabir MD, Gauri Pawar MD, Amelia Adcock MD, Muhammad Alvi MD, Matthew Smith MD Information sharing with the trainees as a method to reduce door-to-needle time for Intravenous administration of tissue plasminogen activator in acute ischemic stroke. International Stroke Conference (ISC), Los Angeles, CA May 2015 Lindsey Sosnowski, Kamal KM, Pawar G. Impact of young-Onset Parkinson’s disease on Quality of Life: A Literature Review. Annual meeting of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR), Philadelphia, PA May 2013 Brewster M, Bondi C, Khairnar R, Kamal KM, Pawar G. A systematic review of quality of life and caregiver burden in Parkinson’s disease. Annual meeting of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR), New Orleans, LA May 2013 Stroyne K, Barna S, Kamal KM, Pawar G. Caregiver burden in multiple sclerosis: A structured review of the instruments. Annual meeting of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR), New Orleans, LA Dec 2012 Rajasekaran V, Weimer T, Pergami P, Pawar GV, Palade A, Does the Amygdala play a role in weight gain after epilepsy surgery? A tertiary care center experience, American Epilepsy Society Annual meeting, San Diego, CA Sept 2011 Pawar GV, Gutmann L, Gyure K. Type 2 myotonic dystrophy and polymyositis. American Association of Neuromuscular and Electro diagnostic Medicine (AANEM) Annual Meeting, San Francisco, CA. Mar 2011 Bhanegaonkar A, Pawar G, Madhavan S Understanding health related quality of life changes and issues related to disease modifying drugs among multiple sclerosis patients: A qualitative study Annual meeting of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR), Baltimore, MD Oct 2007 Chitnis S, Pawar G, Isaac Syndrome in an eight year old, American Association of Neuromuscular and Electro diagnostic Medicine (AANEM) Annual Meeting, Washington, DC Nov 2004 Pawar G, Challenging Electro Diagnostic Case, “Dermatomyositis and Premature Ovarian Failure” American Association of Neuromuscular and Electro diagnostic Medicine (AANEM) Annual Meeting, Savannah, GA Oct 2004 Gutmann L, Pawar GV “Significance of Myokymia associated with Severe Hypoxic-Ischemic Injury”. American Neurological Association Annual meeting, Toronto. Poster Presentation: Local and Institutional

Mar 2016 Aman Dabir, MD Gauri Pawar, MD Matthew Smith, MD Information sharing with the trainees as a method to reduce door-to-needle time for
Revised 6/21/2018
Intravenous administration of tissue plasminogen activator in acute ischemic stroke. EJ Van Liere Convocation & HSC Research Day May 2015 Lindsey Sosnowski, Kamal KM, Pawar G. Gumberg Library Award and “Best Poster Award” Undergraduate Research Symposium, Impact of young-Onset Parkinson’s disease on Quality of Life: A Literature Review. Duquesne University May 2011 Khorasani S, Pawar G. Multiple Extracranial Arterial Dissections, WVU Stroke Conference May 2011 Khorasani S, Pawar G. Fulminant Primary Angiitis of CNS, WVU Stroke Conference, May 2011 Rajasekaran V, Pawar G. Variable Clinical Spectrum of Fibromuscular Dysplasia, WVU Stroke Conference May 2010 Sirinan Tazen, MD & Gauri Pawar, MD “So you think you know all about stroke?” GME Week, WVUSOM May 2010 Hossein Ansari, MD & Gauri Pawar, MD “Charles- Bonnet Syndrome” GME Week, WVUSOM Sept 2008 Haynes Ralsten MD, Gauri Pawar, MD “A case of Leukoareosis in Immune Reconstitution” WVU 1st Annual Stroke Conference, Morgantown WV, Feb 2005 Pawar G, Khan A. “Sleep in Multiple Sclerosis”, West Virginia Sleep Symposium

Abstracts:

1. Quynh Vo, Uzoma Duru, Gauri Pawar Unusual Amnestic Syndrome Associated with Combined Fentanyl and Cocaine Overdose Neurology April 2018; Vol 90 (15 Supplement) 2. Amelia Adcock, Aman Dabir, Gauri Pawar and Muhammad Alvi Using the Adaptive Learning Model to Reduce Door-to-Needle time in Acute Ischemic Stroke Stroke Jan 2018; Vol 49, Issue Supplement 1, AWP 238 3. Sosnowski L, Kamal KM, Pawar G. Impact of young-onset Parkinson's disease on quality of life – A literature review. Value in Health May 2015; Vol.18, Issue 3, A319-A333. 4. Brewster M, Bondi C, Khairnar R, Kamal KM, Pawar G. A systematic review of quality of life and caregiver burden in Parkinson’s disease. Value in Health May 2013; Vol 16: Issue 3, A309-A321 5. Stroyne K, Barna S, Kamal KM, Pawar G. Caregiver burden in multiple sclerosis: A structured review of the instruments. Value in Health May 2013; Vol 16: Issue 3, A309-A321 6. Bhanegaonkar A, Pawar G, Madhavan S Understanding health related quality of life changes and issues related to disease modifying drugs among multiple sclerosis patients: A qualitative study Value in Health May 2011; Vol 14, Issue 3, A211 7. Gutmann Lu, Pawar G, Gutmann La. Transient Neuromyotonia. JPNS 10(suppl. 1) 31, 2005 8. Gutmann L, Pawar GV.
Revised 6/21/2018
Significance of Myokymia Associated with Severe Hypoxic-Ischemic Injury. Annals of Neurology: 56(suppl 8) S40, 2004.


Original Published Peer-Reviewed Articles:

1. “An unusual amnestic syndrome associated with combined Fentanyl and Cocaine use”. Duru UB, Pawar G, Barash JA, Miller LE, Thiruselvam IK, Haut MW. Annals of Internal Medicine – Jan 2018, 895-896 (PMID 29379942)

2. “Cost-effectiveness of peginterferon β-1a and alemtuzumab in relapsing remitting multiple sclerosis” Ankur Dashputre, Khalid Kamal, and Gauri Pawar, M.D. The Journal of Managed Care & Specialty Pharmacy – June 2017 Vol.23, No 6: 666-676

3. “Randomized Trial of Thymectomy in Myasthenia Gravis”, Wolfe GI, Kaminski HJ, Aban IB, et al. New England Journal of Medicine, 2016 Aug 11;375(6):511-22 (PMID 27509100)


4. Siddiqui S, Pawar G, Hogg J : X-Linked ADL Neuroimages Neurology. 2015 Jan 13; 84(2):211. (PMID 25583825)

5. Siddiqui S, Pawar G, Hogg J Vitamin B12 deficiency myelopathy https://3s.acr.org/CIP/Calendar.aspx March 6, 2014

6. “To Scan or Not to Scan.” Tazen, S, Pawar, G, W V Med J 2012 Sep-Oct; 108(5): 36-7 (PMID 23098009)

7. “Comparison of fingolimod with interferon beta-1a in relapsing-remitting multiple sclerosis: A randomized extension of the TRANSFORMS study”’ Khatri B, Barkhof F, Comi G, et al. Lancet Neurology, 2011 Jun; 10(6):520-9 (PMID 21571593)

8. “Oral fingolimod or intramuscular interferon for relapsing multiple sclerosis”, Cohen JA, Barkhof F, Comi G, et al New England Journal of Medicine, 2010 Feb 4;362(5):402-15 (PMID 20089554) 9. “Impact of Visual impairement on Health-Related Quality of Life in Multiple Sclerosis”, Pawar, V., Pawar, G., Miller LA., Kalsekar, I., Kavookjian, J., Scott, V., Madhavan, S. International Journal of MS Care, 2010; 12:83-91.

10. “An Approach to Electro diagnosis of Peripheral Neuropathies”, Gutmann, L., Pawar, G., Seminars in Neurology 25 (2): 2005

11. “Infantile Botulism” Lavoie, L., Pawar, G., Khan, A. W V Med J, 2006 Sep-Oct; 102(5): 19-20 (PMID 17285950)

12. “WVU’s Epilepsy Monitoring Unit Advancing Patient Care.” Palade A., Pawar G., Libell D., Brick, J., Khan A. The West Virginia Medical Journal 2005 May-Jun; 101(3): 107 (PMID 16161527)
Revised 6/21/2018
13. “The use of botulinum toxin injection to treat Excessive Drooling in Children with Neurological Conditions.” Khan A, Pawar G. W V Med J Nov/D 2005 Nov-Dec; 101(6): 25860 (PMID 16625812)

14. “Widespread and lateralized effects of acute traumatic brain injury on Norepinephrine turnover in rat brain.” Levin B., Brown K., Pawar G., Dunn-Meynell A. Brain Res 1995 Mar 20; 674(2):307-13. (PMID 7796111)

Back to top of page


2019 Conference
Speaker Biographies
TBA